BioCentury
ARTICLE | Clinical News

Celtura regulatory update

January 4, 2010 8:00 AM UTC

Novartis said its influenza A (H1N1) 2009 monovalent vaccines Celtura, Focetria and Fluvirin received prequalification from the World Health Organization (WHO) for use in national immunization progr...